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ABSTRACT
Introduction This paper describes the protocol for an 
ongoing project funded by the Royal Society, the Resilience 
After Individual Stress Exposure (RAISE) study; which aims 
to examine the factors and mechanisms that facilitate 
resilient functioning after childhood adversity (CA).
Methods and analysis We aim to recruit up to 200 
participants. We will use dimension reduction techniques 
(principal component analysis) on standard- normally 
transformed individual parameters of mental health, social 
functioning and CA to calculate a composite measure 
of adaptive (ie, ‘resilient’) psychosocial functioning. To 
examine the neuroimmune responses to stress and 
their relationship with the brain and social environment, 
we will use a well validated functional MRI task; the 
Montreal imaging stress task and venepuncture. We will 
run group or dimensional comparisons in multiple levels 
of biological and psychological outcomes, as well as 
mediation and moderation analyses to study how key 
biological systems (ie, the hypothalamic–pituitary–adrenal 
axis and the immune system) interrelate and interact with 
brain function and social influences in order to facilitate 
resilient functioning after CA. We hypothesise that resilient 
functioning will be facilitated by reduced morning cortisol 
and cytokine levels before and after the stressor and 
improved neural responses to such stress, as well as 
increased gray matter volume in the hippocampus and 
prefrontal cortex, enhanced inhibitory control and emotion 
regulation, and more friendship and family support.
Ethics and dissemination This study has been reviewed 
and given favourable opinion by the National Research 
Ethics Service, NRES Committee East of England- 
Cambridge Central and external reviewers from the 
Royal Society (RGF\R1\180064 and RGF\EA\180029). The 
results of the RAISE study will be disseminated through 
(1) publications in scientific peer reviewed journals, (2) 
presentations on relevant scientific conferences and 
meetings, (3) publications and presentations for the 
general public and (4) through social media.
INTRODUCTION
Childhood adversity (CA) is the leading 
preventable risk factor for mental illness and 
substance abuse.1–8 This kind of experiences, 
which can happen within the family environ-
ment (eg, in the form of childhood maltreat-
ment and/or intrafamily adversity) or outside 
the household (eg, trauma and bullying), can 
have a detrimental impact on a wide range of 
functions. For example, CA has been associ-
ated with physical (eg, failure to thrive, poor 
adult health and high mortality), cognitive 
(eg, impaired inhibitory control and emotion 
regulation) and personal and interper-
sonal problems (eg, negative self- cognitions, 
suicidal behaviours, increased peer rejection, 
social withdrawal, sexual maladjustment, 
aggression and criminality).8–16
Importantly, adolescents with CA are at 
increased risk for and are more sensitive 
to psychosocial stress. In response to acute 
stress, the body reacts by releasing pro- 
inflammatory cytokines, such as interleukin-6 
(IL-6) and tumour necrosis factor alpha 
(TNF-α).17 These cytokines play a key role in 
stress reactivity and stress recovery.18 Specif-
ically, proinflammatory cytokines stimulate 
the hypothalamic–pituitary–adrenal (HPA) 
axis to release glucocorticoid hormones such 
Strengths and limitations of this study
 ► The Resilience After Individual Stress Exposure 
study will provide a comprehensive evaluation of 
the neurobiological mechanisms that contribute to 
adolescent resilience.
 ► We will use standardised and validated instruments 
of psychological functioning, childhood adversity, 
cognitive tasks, venepuncture and neuroimaging.
 ► The exclusion of psychiatric patients will restraint 
the data to the resilience side of the spectrum.
 ► Child adversity will be assessed from self- reports 
that are subjected to reporting biases.
 ► A longer recruitment period may be required due to 
COVID-19.
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as cortisol. Glucocorticoids, in turn, suppress the further 
release of cytokines from the immune system.19 Thus, 
cortisol is an important anti- inflammatory compound in 
the body that is crucial for stress recovery. Proinflamma-
tory cytokines and chemokines can cross the blood–brain 
barrier and negatively impact the function of brain regions 
involved in threat, reward and executive functioning.20 21 
Indeed, acute stress has been associated with increased 
levels of proinflammatory cytokines in the amygdala 
and decreased proinflammatory cytokines in the medial 
prefrontal cortex (MPFC)22; regions associated with exec-
utive functions and emotion regulation.23–28 Therefore, 
it is plausible that the alteration of these processes, or 
the inability to properly value and manage emotions, can 
lead to anxiety and/or depression in situations of nega-
tive affect.29–31
However, although CA is associated with considerably 
lowered odds of adequate mental and physical health 
functioning later in life, a significant proportion of individ-
uals with a history of CA function ‘better than expected,’ 
or, in other words, are ‘functioning resiliently’.32 These 
individuals may have benefited from protective ‘resil-
ience factors’33 34 which exist across social, cognitive, 
neuronal, physiological and genetic levels. For example, 
good mental health after CA has been associated with 
increased hippocampal volume and greater connectivity 
between the central executive network and limbic regions 
as well as a greater ability to regulate emotions,35 higher 
self- esteem36 37 and social support.32 38
OBJECTIVES AND HYPOTHESIS
Resilient functioning has been associated with various 
components, ranging from genes and cellular mecha-
nisms to higher- order biological systems and the social 
environment (see reviews in refs. 39–41; figure 1). 
However, it is yet unknown whether and how neuro- 
immune responses to psychosocial stress differ in resil-
ient vs. vulnerable adolescents with a history of CA. In 
this study, we aim to test the factors and mechanisms that 
facilitate resilient functioning, the interactions between 
those factors, and how they explain resilient responses 
to future stress. Specifically, we will address resilience by 
investigating how key biological systems (ie, the HPA axis 
and the immune system) interrelate and interact with 
brain structure, brain function and social influences to 
facilitate resilient functioning after CA.
Figure 1 The complex neurobiology of resilience after childhood maltreatment (CM).39 Resilient functioning in those individuals 
who have experienced CM may be facilitated by larger prefrontal cortex (PFC) and hippocampal volume and connectivity, the 
ability to adequately regulate emotions and dampen stress responsivity, cortisol and proinflammatory baseline and responses, 
polygenic resilience effects, social support from the immediate environment, and the wider ecology. For readability, the location 
of the hippocampus is not correct. 5- HTTLPR, serotonin- transporter- linked polymorphic region; ACTH, adrenocorticotropic 
hormone; BDNF, brain- derived neurotrophic factor; FKBP5, FK binding protein 5; IL-6, interleukin 6; MAOA, monoamine oxidase 
A; mPFC, medial PFC; NPY, neuropeptide- Y; TNFα, tumour necrosis factor-α.
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All included participants will complete an online assess-
ment to assess psychological functioning and early life 
experiences, an in- unit assessment day to assess neuro-
immune and cognitive responses to stress and an online 
follow- up assessment to assess psychological functioning 
after stress exposure. Resilient functioning will be quan-
tified as the degree to which an individual functions 
better or worse than expected given their self- reported 
CA experiences (32 39; figure 2). Specifically, to examine 
the neuroimmune responses to stress and their relation-
ship with brain structure and function and the social 
environment, we will use a well- validated functional MRI 
(fMRI) task, the Montreal imaging stress task (MIST) and 
venepuncture. Since stress increases circulating inflam-
matory protein levels in the blood, and high levels of 
inflammation predict later mental health disorders, we 
will examine whether resilience is related to lower levels 
of inflammation in response to psychosocial stress, and 
whether this is explained by improved brain responses to 
stress.
We hypothesise that resilient functioning will be facili-
tated by
1. Reduced morning cortisol and cytokine levels before 
and after the stressor (ie, a latent factor constructed 
by serum high- sensitivity C reactive protein (hs- CRP), 
TNF-α, IL-6 and IL-1 factor beta (IL-1β) levels, as these 
have been shown to be increased in those with CA and 
mental illness.42–46
2. Reduced stress- related brain responses (ie, amygdala, 
insula) and increased modulatory responses in the 
MPFC and anterior cingulate cortex (ACC)47–49 during 
the MIST.
3. Increased functional connectivity between the dor-
sal MPFC (DMPFC) and emotion processing regions 
(eg, insula, amygdala and hippocampus) during the 
MIST.50
4. Increased grey matter volume in the hippocampus and 
prefrontal cortex.35 51–57
5. Enhanced cognitive and emotional executive perfor-
mance in behavioural tasks of inhibitory control and 
emotion regulation.29
6. Higher self- esteem and more friendship and family 
support which will aid lower anxiety and perceived 
stress after the MIST.36 58
7. Finally, we expect that the neurocognitive mechanisms 
that facilitate resilient functioning to stress at in- unit 
assessment will be related to improved cognitive and 
emotional functioning at follow- up (lower rumination, 
lower interpersonal stress, improved mood) in line with 
the neuroimmune network hypothesis21 (figure 3).
Figure 2 Risk to Resilient functioning in the NSPN sample of n=1980 adolescents.32 Green and red lines indicate functioning 
that is better or ‘resilient’ (green) or worse ‘vulnerable’ (red) than expected. Psychosocial functioning reflects a factor score 
(mean=0, SD=1) derived from multiple measures of psychiatric symptomatology, personality traits and mental well- being. CA 
reflects a factor score (mean=0, SD=1) from two measures which assess early life family experiences. 5- HTTLPR, serotonin- 
transporter- linked polymorphic region; BDNF, brain- derived neurotrophic factor; CA, childhood adversity; FKBP5, FK binding 
protein 5; IL-6, interleukin 6; MAOA, monoamine oxidase A; MPFC, medial prefrontal cortex; NPY, neuropeptide- Y; NSPN, 
Neuroscience in Psychiatry Network.
Figure 3 The neuroimmune network hypothesis of child 
maltreatment. Inflammatory protein and brain responses to 
psychosocial stress mediate the relationship between CA and 
psychological functioning. CA, childhood adversity; DMPFC, 
dorsal medial prefrontal cortex.
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Recent research suggests that the link between CA and 
immune markers in the blood are small for hsCRP 
immune biomarkers in adults with depression (hsCRP 
r=0.1559). However, there are no studies investigating 
immune biomarkers in response to stress in adoles-
cents. Therefore, it is difficult to determine the neces-
sary sample size for our study. For instance, sample 
sizes for an intended power of 80% are r=0.15: n=345; 
r=0.2: n=193; r=0.3: n=84. Furthermore, it is well estab-
lished that sample correlations show fluctuations and are 
unstable in smaller samples. Simulation studies show that 
for a stable (ie, replicable and generalisable) correlation, 
any sample would need to approach N=250 individuals.60 
For this reason, to increase power to find small effects, 
we will recruit N=200 participants. With this sample size, 
our study is appropriately powered to detect correlations 
from r>0.19.
Participants will be recruited from the general popula-
tion and from previous studies conducted in the Depart-
ment of Psychiatry of the University of Cambridge. First, 
we will contact participants from the Neuroscience in 
Psychiatry Network (NSPN) study who agreed to be 
contacted again. NSPN is a multicentre accelerated 
longitudinal community cohort study (N=2389) focusing 
on normative adolescent to young adult development 
(between the ages of 14 and 24). Overall, this sample can 
be described as healthy, reporting low levels of psycho-
pathological symptoms, behaviours and/or personality 
traits, and average mental well- being scores. From this 
cohort, we will contact those who agreed to be contacted 
for future research of whom family adversity scores were 
in the highest 25% of the entire NSPN cohort (≥75%=597 
eligible individuals) as assessed by van Harmelen et al.32 
Family adversity scores in NSPN were calculated using a 
principal component analysis (PCA) on standard- normally 
transformed sum scores for the Measure of Parenting 
Style (MOPS) and the Alabama Parenting Questionnaire 
(APQ). Eligible participants will be contacted via email 
first. This email will include the participant informa-
tion sheet (PIS) of the study. A reminder email will be 
sent after a month. Finally, we will contact those partici-
pants who cannot be reached by email via phone call. To 
recruit participants from the general population we will 
distribute flyers and advertisements in colleges, Adden-
brooke’s hospital and online. Individuals expressing an 
interest in the study could either email or telephone a 
member of the research team and leave their contact 
details. A member of the Resilience After Individual 
Stress Exposure (RAISE) study research team will then 
phone interested individuals. During the telephone call 
a member of the research team will discuss the content 
of the PIS and assess the inclusion and exclusion criteria 
in order to ensure they are eligible and fully aware of the 
nature of the study. Eligible participants will be emailed 
the PIS of the study. Potential participants will be given 
the opportunity to raise any queries regarding any aspect 
of the study including confidentiality, anonymity, storage 
and use of data, as well as the right to withdraw.
The inclusion criteria will be: aged 16–26 years old; 
able and willing to give informed consent; able to speak, 
write and understand English; body mass index (BMI) 
between 18.5 and 29.9 kg/m2; have experienced adverse 
life experiences and/or CA within the family environ-
ment including childhood maltreatment (eg, emotional, 
sexual and/or physical abuse, emotional and/or physical 
neglect) and intrafamily adversity (eg, marital distress/
conflict, parental mental health problems and/or 
parental alcohol dependence, violence and/or aggressive 
behaviour) before the age of 16; and willing to abstain 
from strenuous exercise for 72 hours prior to the in- unit 
assessment.
The exclusion criteria will be: alcohol or substance use 
disorder within the past 6 months; current disorders likely 
to compromise the interpretation of the data (including, 
but not limited to, psychiatric disorders, immunolog-
ical disorders, cardiovascular disorders, endocrine and 
autoimmune disorders, malignancies or infections, or 
any other condition to be determined by the principal 
investigator or delegate); current medication likely to 
compromise the interpretation of immunological data 
(including, but not limited to, corticosteroids or any 
other substance to be determined by the principal inves-
tigator or delegate); and contraindications to MRI (eg, 
pacemaker or other implantable device or pregnancy).
Testing protocol and procedure
All included participants will be asked to complete three 
phases:
Phase I: an online assessment to assess psycholog-
ical functioning and early life experiences; phase II: an 
in- unit assessment to assess neuroimmune and cognitive 
responses to stress, and phase III: an online follow- up 
assessment to assess psychological functioning after stress 
exposure. Please see figure 4 and sections below for a 
description of the measures included in each phase.
Phase I: online assessment
The online assessment will include signing an informed 
consent form (ICF), the completion of a set of self- report 
questionnaires and two cognitive tasks online. The self- 
report questionnaires included in this assessment will be 
the Mood and Feelings Questionnaire (MFQ61), Revised 
Children’s Manifest Anxiety Scale (RCMAS62), Leyton 
Obsessional Inventory (LOI63), the 10- item version of the 
Kessler Psychological Distress Scale (K1064), the Child 
Behaviours Checklist (CBC65), the Warwick- Edinburgh 
Mental Well- being Scale (WEMWBS66), the MOPS67, the 
APQ68, the Cambridge Friendship Questionnaire, Family 
Assessment Device (FAD69 70), Rosenberg Self- Esteem 
Scale71, Childhood Trauma Questionnaire (CTQ72) and 
the Drugs, Alcohol and Self- Injury Inventory.73. These 
questionnaires will be used to calculate a composite 
measure of resilient functioning as described below. The 
cognitive tasks will be the Emotional Stroop task74 and 
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Emotional Regulation task.75 More information about 
these measures is provided in the online supplemental 
material.
Phase II: in-unit assessment
Following completion of the online assessment, partic-
ipants will be contacted to schedule an appointment at 
Addenbrooke’s Hospital (Cambridge, UK), after which 
they will receive a letter with the appointment details. This 
letter will include clothing and make- up regulations for 
brain scanning, time and location of the facilities where 
the evaluations will take place, as well as the research 
team’s contact details. It will also reiterate that partici-
pation is voluntary and that participants can withdraw at 
any given time during the study. The second assessment 
will have a duration of 5 hours and will include (1) the 
completion of a second ICF, (2) a clinical evaluation, (3) 
a research nurse protocol, (4) an MRI session and (5) the 
completion of a second set of self- report questionnaires. 
Please see the sections below for a description of the 
instruments included in each assessment.
Clinical evaluation
Participants will be asked to attend the clinical research 
facility at Addenbrooke’s Hospital at 9:00 hours, where 
they will be given a detailed overview of the study, asked to 
sign the ICF, and receive a low- fat breakfast adapted to their 
nutritional needs. The breakfast provided will exclude 
antioxidants such as glutathione and vitamins E and C to 
reduce the effects of these variables on the inflammatory 
markers addressed.76 Subsequently, the clinical evaluation 
will take place. This session will include the evaluation of 
psychiatric disorders, handedness, physical activity, sleep 
and eating patterns, medications (eg, oral contraception) 
and intellectual functioning. Specifically, we will use the 
following measures: The Mini- International Neuropsychi-
atric Interview77, The Edinburgh handedness inventory,78 
The Short- form Frequency Food questionnaire79 and The 
Wechsler Abbreviated Scale of IntelligenceWASI80. The 
measures used will be supplemented with an interview. 
See the online supplemental material for a description of 
the instruments used in this evaluation.
Physiological evaluation protocol
The clinical assessment will be followed by a physiological 
evaluation protocol. A research nurse will assess physical 
variables such as body temperature, height, weight, waist 
circumference, blood pressure (systolic and diastolic) 
and will implant a cannula to take blood samples during 
the assessment day.
Venepuncture
The implantation of the cannula will be conducted 
according to the standard Cambridge Clinical Research 
Facility protocol with risk protocols in place. These proce-
dures include a brief interview about adverse experiences 
with blood assessment (such as fainting), as well as their 
preference for one arm or the other and if they want to 
lie down, or sit upright during the implantation of the 
cannula. Up to 30 mL of venous blood will be collected 
per participant for the measurement of cortisol, blood 
cytokines and immunophenotyping (ie, basic immune 
Figure 4 Summary of the study protocol. APQ, Alabama Parenting Questionnaire; CBC, Child Behaviours Checklist; CFQ, 
Cambridge Friendship Questionnaire; CTQ, Childhood Trauma Questionnaire; DASI, Drugs Alcohol and Self- Injury; EHI, 
Edinburgh Handedness Inventory; ERT, Emotion Regulation Task; FAD, Family Assessment Device; IPSM, Interpersonal 
Sensitivity Measure; K10, Kessler Psychological Distress Scale; LEQ, Life- Events Questionnaire; LOI, Leyton Obsessional 
Inventory; MFQ, Mood and Feelings Questionnaire; MINI, Mini- International Neuropsychiatric Interview; MIST, Montreal Imaging 
Stress Task; MOPS, Measureof Parenting Style; MPRAGE, T1- Weighted rapid three- dimensional radient- echo; PSS, Perceived 
Stress Scale; RCMAS, Revised Children's Manifest Anxiety Scale; RRS-10, Ruminative Response Scale; RSES, Rosenberg 
Self- Esteem Scale; rs- fMRI, restingstate functional MRI; SFFFQ, Short- Form Frequency Food Questionnaire; STAI, State- Trait 
Anxiety Inventory; WASI, Wechsler Abbreviated Scale of Intelligence; WEMWBS, Warwick- Edinburgh Mental Well- Being Scale.
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cell counts and cell phenotyping). Blood will be extracted 
using an intravenous catheter inserted in the antecubital 
vein of the arm of the participants. A 30 min following 
catheter insertion, the participants will undergo MRI 
scanning and will perform the psychological stress task 
(ie, MIST). A 1.2 mL K2 Ethylenediamine Tetraacetic 
Acid (EDTA) tubes will be taken for the analysis of 
immunophenotyping, 2.6 mL serum white tap tubes for 
the analysis of cytokines and 4.6 mL serum brown tap 
tubes for the analysis of cortisol. Bloods will be acquired 
at four time points: (−T1) 45 min before the start of the 
task (baseline line), (T0) right before the start of the task, 
(T30) right after the end of the task (peak cortisol) (T80) 
80 min after the start of the task (delayed immune reac-
tions).81 Please see figure 5 for a representation of the 
venepuncture protocol.
Neuroimaging protocol
Before the scan, participants will complete an MRI 
screening form, the State- Trait Anxiety Inventory,82 and 
practice the MIST. Each participant will be in the MRI 
scanner for about 50 min. The MRI scanning session will 
comprise the following MRI sequences:
T1- weighted three- dimensional magnetisation- 
prepared rapid gradient- echo (MPRAGE) (6 mins). High 
spatial resolution T1- weighted structural scans will be used 
to aid normalisation and visualisation of each of the other 
MRI modalities (as described below) and analyse brain 
structure (ie, cortical thickness, grey matter volume).
Resting state functional MRI (fMRI) (7 mins). A resting 
state fMRI will be used to investigate effects of inflamma-
tion on brain functional connectivity.
MIST (30 mins). We will use a modified version of 
the MIST83. This task comprises a series of computer-
ised mental arithmetic tasks with an induced failure 
component. The protocol consists of a training session 
conducted outside the imaging unit, and a test session 
during which the functional images are acquired. Please 
see the online supplemental material for a description of 
the paradigm.
After the MRI session, participants will be debriefed. 
We will tell them that the task was designed to be impos-
sible to accomplish and that it did not truly assess their 
ability to perform mental arithmetic. Then, we will ask 
them to complete the STAI- State, MFQ, Life Events Ques-
tionnaire,84 and any questionnaire from the online assess-
ment that is incomplete. After completion of the post- MRI 
session, the participants will have a standard meal and be 
given time to relax. In addition, we will have a protocol 
for debriefing, an information letter with relevant types 
of support available, and a distress protocol in case the 
participant reports severe distress.
Phase III: follow-up online assessment
The follow- up and final assessment will be completed 
online within a month from the in- unit assessment and 
will include the third and last online ICF, the MFQ, 
RCMAS and LEQ, as well as the following measures 
described in the online supplemental material: Perceived 
Stress Scale85, Interpersonal Sensitivity Measure86 and the 
10- item Ruminative Response Scale.87
Please see the online supplemental material for a rela-
tion of the main risk and ethical issues associated with this 
protocol.
Patient and public involvement
A group of three adolescents participated in a Lived 
Experience Advisory group to assess the protocol and 
materials included in the study (eg, PIS, consent forms, 
questionnaires, etc). We have made the following changes 
as a result of their feedback: (1) we have included a risk 
protocol in case a participant feel distressed during the 
completion of the questionnaires, (2) we have increased 
the payment for the completion of the study to account 
for the time burden of the questionnaires and the distress 
Figure 5 Venepuncture protocol. Bloods will be acquired at four time points: (−T1) 45 min before the start of the task, (T0) Just 
before the start of the task (T30) right after the start of the task, (T80) 80 min after the start of the task. dMPFC, dorsal medial 
prefrontal cortex; MIST, Montreal Imaging Stress Task
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associated with the cannulation and (3) we have modified 
the PIS in accordance with their suggestions.
ANALYSES
Clinical, questionnaire and immunological data will be 
descriptively summarised. The significance threshold will 
be set at p<0.05 and Family- Wise Error (FWE) corrections 
will be applied to correct for multiple comparisons.
Preprocessing
Quantification of resilient functioning
Using the data collected during the first online assess-
ment, we will calculate gender and age- related degree of 
resilient functioning based on the model described in van 
Harmelen et al32; see also Ioannidis et al39 for a description 
of the benefits and pitfalls of this method. Specifically, 
we will conduct two PCAs; one for psychosocial func-
tioning using standard- normally transformed individual 
total scores on the MFQ, RCMAS, LOI, CBC, K10 and 
WEMWBS; and another one for CA, including standard- 
normally transformed sum scores for the MOPS, APQ, 
FAD and CTQ. From both analyses, we will extract indi-
vidual scores for the first component to reflect individual 
current psychosocial functioning and recalled CA experi-
ence scores. Next, we will regress the psychosocial func-
tioning component score against the CA score, testing 
for possible linear, quadratic or cubic relationships. 
From this model, we will extract the residual scores as a 
measure of individual degree of resilient functioning: the 
extent to which an individual has better, or worse, psycho-
social functioning than the average score expected given 
their CA experiences. For parsimony, we will refer to this 
as degree of ‘resilient functioning’ with higher scores 
reflecting better (conditional) psychosocial functioning 
outcomes. These individual resilient functioning scores 
will be used in the analyses described below.
Imaging preprocessing
Task- evoked and resting state fMRI data will be 
preprocessed using Statistical Parametric Mapping 
12 (SPM12) (http://www. fil. ion. ucl. ac. uk/ spm/ soft-
ware/ spm12/) and the CONN toolbox (https:// web. 
conn- toolbox. org/) implemented in MatLab R2019b 
(Mathworks, Natick, Massachusetts, USA). Images will 
be corrected for movement artefacts, coregistered 
with the T1- weighted images, normalised to a standard 
EPI template in the Montreal Neurological Institute 
space and spatially smoothed with an 8 mm FWHM 
Gaussian kernel. Quality control will be performed 
after each preprocessing step. Structural MRI will be 
analysed using the FreeSurfer image analysis suite, 
which is widely documented and freely available online 
(http:// surfer. nmr. mgh. harvard. edu/).
Cortisol and immune markers preprocessing
Blood samples will be processed at the Core Biochem-
ical Assay Laboratory (blood cytokines), Pathology 
(cortisol) and Immunology laboratory (immunophe-
notyping) at Addenbrookes Hospital (Cambridge, 
UK). A 1 mL of blood will be diluted 1:1 with phos-
phate buffered saline and stimulated with lipopoly-
saccharide (LPS) (LPS challenge) to analyse the 
production of IL-6 and other cytokines difficult to 
detect.88 89 LPS- stimulated IL-6 and IL-1β production 
in peripheral leukocytes will be processed following 
a protocol originally developed by DeRijk et al.90 All 
cytokines, including serum TNF-α and hs- CRP will be 
measured using the MSD platform.
Phenotyping
A 50–100 uL of blood will be used for the enumeration 
of the major populations of immune cells (monocytes, 
granulocytes, NK cells, NKT cells, CD4+ and CD8+T 
cells and B cells). We will use multicolour flow cytom-
etry to count and analyse the size, shape and properties 
of individual cells within heterogeneous populations. 
We will use multivariate methods (partial least squares 
(PLS) and PCA) to reduce dimensionality and define 
populations of differentially coexpressed cell counts 
and the unbiased gating algorithm Spanning- tree 
Progression Analysis of Density- normalised Events 
(SPADE). SPADE generates an immune cell hierarchy 
by clustering phenotypically similar cells into groups 
which can be enumerated.
Statistical analyses
Age, gender, socioeconomic status and education level will 
be included as covariates in all analyses. Additionally, for the 
imaging analysis, we will include the total volume of grey 
matter (for the analyses of grey matter), a high- pass filter uses 
to remove low- frequency drifts in the data (for the analysis of 
fMRI data), and the signal fluctuations in white matter and 
cerebrospinal fluid and the subject- specific six realignment 
parameters and their first order derivatives (for the anal-
yses of functional connectivity). Finally, phase of menstrual 
cycle, BMI, and tobacco smoking will be used in the analyses 
involving immune/cortisol markers.
Hypothesis 1: Individuals with higher resilient functioning 
will display lower baseline cortisol and blood cytokines, faster 
habituation and less cortisol volatility.
We will use a PCA to derive a factor score for endocrine 
or inflammatory markers at the different time points. We 
expect there will be two components: one relating to base-
line cortisol (or index of immune biomarkers), and one 
relating to cortisol change (or index of immune responsivity; 
see91 for a similar approach). We will then use area under 
curve (AUC) analyses to examine whether degree of resil-
ient functioning is more strongly associated with general 
immune status (ie, the baseline cortisol measure) or cortisol 
responsivity (ie, area under the curve with respect to ground 
(AUCG) and area under the curve with respect to increase 
(AUCI) (see
92 for specifics). We will validate this result using 
a simple multivariate regression to examine whether the two 
components of immune functioning independently predict 
resilient functioning outcomes.
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Hypotheses 2–4: Higher resilient functioning is associ-
ated with more balanced and integrated neural systems:
For the event- related fMRI analysis, we will use both 
whole- brain and regions of interest (ROIs) approaches. 
To examine the effect of stress, we will examine brain 
responses to the contrast ‘experimental +control condi-
tion’ vs ‘rest condition’. Then, in a second level analysis, 
we will conduct a multiple regression analysis with resil-
ience scores as regressor of interest. The ROIs use will 
be the MPFC, ACC, amygdala, insula and hippocampus. 
Finally, we will run a psychophysiological interaction anal-
ysis to test hypothesis 3 (ie, increased functional connec-
tivity between the DMPFC and emotion processing 
regions during the MIST).
For the analysis of resting state fMRI, we will use whole- 
brain and ROIs approaches. Our first approach will be 
a data- driven analysis. We will use intrinsic connectivity 
contrast (ICC93). The use of ICC does not require a 
priori selection of a seed region but instead objectively 
defines how well each voxel is connected to the rest of 
the brain. Following the calculation of a resting state 
ICC map for each participant, we will test associations 
between ICC maps and resilient functioning. Specif-
ically, we will correlate resilient functioning with the 
voxel level ICC using a multiple regression analyses in 
SPM. Finally, we will calculate functional connectivity 
maps and network involvement of the regions found to 
be associated with resilient functioning.
The significance thresholds will be set at p<0.05 after FWE 
correction for multiple comparisons across the whole- brain 
(pFWE <0.05) or the voxels of the different ROIs (ie, using 
small volume correction (SVC) procedures (pFWE- SVC 
<0.05).
Hypotheses 5 and 6: Individuals with higher resilient 
functioning will display better cognitive control and 
greater levels of social support.
We will use Structural Equation Modelling to 
examine the relations and interrelations described in 
hypotheses 5 and 6. Specifically, we hypothesise that, 
using a multiple indicators multiple causes model, we 
will observe that individual differences in outcome 
(cognitive functioning) will be explained by partially 
independent and complementary neural systems (ie, 
all paths shown will be significant when estimated 
simultaneously).
Hypothesis 7: Neurocognitive mechanisms that 
facilitate resilient functioning to stress are related 
to improved cognitive and emotional functioning at 
follow- up.
Using mediation modelling (eg, figure 2), we will 
examine whether the mechanisms that facilitate resilient 
functioning to stress are related to improved cognitive 
and emotional functioning (ie, rumination, interper-
sonal stress, mood, etc) at follow- up.
Immunophenotyping analyses
We will assess immunophenotyping data to determine 
whether or not resilient adolescents can be distinguished in 
terms of immunophenotype levels. The proportion of each 
immune cell type will be used as the predictor variables in 
a PLS analysis, with resilient functioning as the response 
variable. Using this method, we hope to identify immune 
patterns that are associated with resilient functioning.
CURRENT STATUS
This study has been reviewed and given favourable opinion 
by the National Research Ethics Service, NRES Committee 
East of England- Cambridge Central and external reviewers 
from the Royal Society (RGF\R1\180 064 and RGF\
EA\180029). We are currently at year 3 of the project. As of 
March 2020, 102 participants have been recruited for the 
study. From those, 62 have completed phases I, II and II of 
the study. Only ten participants have withdrawn following 
informed consent due to various reasons (eg, scheduling 
conflicts, presence of mental health disorders or found 
images presented in the Emotional Regulation Task overly 
distressing). Additionally, of the adolescents screened, the 
most common reasons for ineligibility are MRI incompati-
bility (eg, dental braces), current psychotropic medication 
and BMI outside 18–30. Due to the uncertainty caused by the 
COVID-19 outbreak, we cannot anticipate when we will be 
able to finish the recruitment of our participants. However, 
we are approaching community organisations and agencies 
across Cambridge, including agencies working with victims 
of trauma to aid in the recruitment of participants with CA, 
and therefore, we anticipate the finalisation of the recruit-
ment in 3 months from the time we start recruiting again.
DISCUSSION
The RAISE study aims to examine how resilient adoles-
cents react to psychosocial stress in order to better under-
stand the neurobiological mechanisms that contribute to 
adolescent resilience. We will examine how key biological 
systems (ie, the HPA axis and the immune system) interre-
late and interact with brain function and social influences 
in order to facilitate resilient functioning after CA. We 
hypothesise that resilient functioning would be facilitated 
by reduced baseline cortisol and cytokine levels before 
and after the stressor (ie, a latent factor constructed by 
serum hs- CRP and TNF-α and IL-6 and IL-1β levels) as 
these have been shown to be increased in those with CA, 
mental illness, reduced stress related brain responses (ie, 
amygdala, insula), and increased modulatory responses 
in the MPFC and ACC during the MIST. Moreover, we 
expect to find that the neurocognitive mechanisms that 
facilitate resilient functioning to stress during the in- unit 
assessment will be related to improved cognitive and 
emotional functioning at follow- up (lower rumination, 
lower interpersonal stress, improved mood). The findings 
from this study will help us to determine what sets resil-
ient individuals apart on a neurobiological level. Such 
knowledge will be helpful to inform intervention strate-
gies for individuals with a history of CA to prevent the 
development of mental health disorders, and ultimately, 
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increase resilience in individuals who have experienced 
adversity in early life. Although we will take a dimensional 
approach, examining individual variation in degree 
of resilient functioning and including individuals with 
past histories of psychiatric disorders and subthreshold 
mental health disorders, the exclusion of patients with 
current psychiatric disorders will limit the interpret-
ability of the data and our findings. Future studies should 
include participants with current mental health disorders 
to ensure the representation of both dimensions of the 
spectrum.
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